Do you mean one of these?
1) Active Pharmaceutical Ingredient (API) for human medicines
- What it is: The chemical substance that provides the pharmacological activity in a drug product intended for humans.
- Key points:
- Regulation: Must be manufactured under GMP; API firms often provide certificates of analysis and impurity profiles.
- Quality standards: Identity, potency, purity; impurities per ICH Q3A/Q3B; residual solvents per ICH Q3C; moisture content, etc.
- Regulatory filings: In the US/EU, APIs may be supplied under a Drug Master File (DMF) or Certificate of Suitability (CEP). Drug products combine APIs with excipients and must pass quality tests.
- Sourcing and handling: Buy from GMP-certified manufacturers or CMOs; verify COAs and stability data; consider salt form, polymorph, and storage requirements.
- Common considerations: stability, solubility, salt/hydrate forms, potential impurities, batch-to-batch consistency.
- If you want, tell me your country and the specific API, and I can outline the regulatory steps, typical testing, and sourcing options.
2) An API (application programming interface) for human-use health data
- What it is: A software interface that lets apps retrieve drug information, dosing guidelines, interactions, etc.
- Examples you might use:
- NLM RxNorm API (drug terminology and normalization)
- DailyMed API (FDA labeling information)
- OpenFDA Drug API (adverse events, product labeling)
- DrugBank API (drug data)
- How to use: Register for access, choose endpoints (lookup by name, NDC, mechanism, etc.), handle versioning and rate limits, and ensure data licensing and privacy compliance.
- Considerations: data freshness, licensing, accuracy, and patient privacy when building clinician- or patient-facing tools.
If you can clarify which you mean (API for human medicines, or a software API for health data), I can tailor details, regulatory steps, and concrete examples.